title: Rare EGFR exon 20 S768I mutation predicts resistance to targeted therapy: a report of two cases.
authors.affiliation: Department of Oncology, New Cross Hospital, Wolverhampton, United Kingdom Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom Department of Oncology, New Cross Hospital, Wolverhampton, United Kingdom.
authors.forename: Lalit
authors.initials: L
authors.lastname: Pallan
authors.forename: Phillipe
authors.initials: P
authors.lastname: Taniere
authors.forename: Pek
authors.initials: P
authors.lastname: Koh
mesh_terms: D000368:Aged; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D005091:Exons; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*
chemical_list: D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors